AI scans could predict lung trouble in scleroderma patients

NCT ID NCT06472362

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Royal Brompton & Harefield NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 27 times

Summary

This study looks at 1000 people with systemic sclerosis (scleroderma) to see if a computer can analyze their CT scans and predict if their lung disease will get worse. Researchers will check if certain features on the scans are linked to survival, lung function decline, and development of pulmonary hypertension. The goal is to find better ways to identify who needs early treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bichat-Claude Bernard hospital

Paris, France
Hanover Medical School

Hanover, Germany
Leeds Hospital/University of Leeds

Leeds, United Kingdom
Marche Polytechnic University

Ancona, Italy
Royal Brompton Hospital

London, United Kingdom
Sassari University

Sassari, Italy
Siena University Hospital

Siena, Italy

Conditions

Explore the condition pages connected to this study.

SYSTEMIC SCLEROSIS SYSTEMIC SCLEROSIS